Skip to main content
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research logoLink to Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
. 2023 Jul 20;29:e941845-1–e941845-2. doi: 10.12659/MSM.941845

Errate: Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity

Jiaxing Wang 1, Fakun Huang 2, Caiyun Jiang 3, Pan Chi 1,
PMCID: PMC10368140  PMID: 37470125

It was brought to our attention by the authors that Figures 5A and 6A contained errors.

The correct version of Figures 5A and 6A are provided below.

The corrected figures do not change the overall findings of the study.

graphic file with name medscimonit-29-e941845-g005A.jpg

graphic file with name medscimonit-29-e941845-g006A.jpg

Reference

  1. Wang Jiaxing, Huang Fakun, Jiang Caiyun, Chi Pan. Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity. Med Sci Monit. 2020;26:e915854. doi: 10.12659/MSM.915854. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medical Science Monitor : International Medical Journal of Experimental and Clinical Research are provided here courtesy of International Scientific Information, Inc.

RESOURCES